Michael Taymor, MD
Pediatrics · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 1
- 1 carrier
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Taymor’s office at (650) 321-7722 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 15 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 15 | $0 |
| 2024 | 15 | 1 | 14 | $0 |
| 2023 | 75 | 3 | 15 | $1,092 |
| 2022 | 69 | 2 | 18 | $2,349 |
| 2021 | 268 | 5 | 23 | $7,952 |
| 2020 | 395 | 7 | 28 | $17,444 |
| 2019 | 499 | 7 | 25 | $22,717 |
| 2018 | 552 | 8 | 24 | $29,784 |
See the largest Medicaid services in earlier years
2023
| Distortion product evoked otoacoustic emissions; comprehensive diagnostic evaluation (quantitative analysis of outer hair cell function by cochlear mapping, minimum of 12 frequencies), with interpretation and report | 15 | $939 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 13 | $121 |
| Short return visit (20+ min) | 47 | $32 |
2022
| Distortion product evoked otoacoustic emissions; comprehensive diagnostic evaluation (quantitative analysis of outer hair cell function by cochlear mapping, minimum of 12 frequencies), with interpretation and report | 38 | $2,287 |
| Short return visit (20+ min) | 31 | $62 |
2021
| Developmental screening | 72 | $4,779 |
| Distortion product evoked otoacoustic emissions; comprehensive diagnostic evaluation (quantitative analysis of outer hair cell function by cochlear mapping, minimum of 12 frequencies), with interpretation and report | 46 | $2,802 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 34 | $371 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 62 | $0 |
| Return visit (30+ min) | 54 | $0 |
2020
| Developmental screening | 115 | $7,706 |
| Distortion product evoked otoacoustic emissions; comprehensive diagnostic evaluation (quantitative analysis of outer hair cell function by cochlear mapping, minimum of 12 frequencies), with interpretation and report | 93 | $5,866 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 15 | $1,582 |
| EVALUATION OF WHEEZING | 28 | $1,505 |
| Return visit (30+ min) | 53 | $658 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 12 | $127 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 79 | $0 |
2019
| Developmental screening | 170 | $11,347 |
| Distortion product evoked otoacoustic emissions; comprehensive diagnostic evaluation (quantitative analysis of outer hair cell function by cochlear mapping, minimum of 12 frequencies), with interpretation and report | 113 | $6,904 |
| EVALUATION OF WHEEZING | 50 | $2,678 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 13 | $1,390 |
| Return visit (30+ min) | 127 | $252 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 14 | $147 |
| Short return visit | 12 | $0 |
2018
| Developmental screening | 159 | $10,677 |
| Distortion product evoked otoacoustic emissions; comprehensive diagnostic evaluation (quantitative analysis of outer hair cell function by cochlear mapping, minimum of 12 frequencies), with interpretation and report | 152 | $9,422 |
| EVALUATION OF WHEEZING | 80 | $4,532 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 33 | $3,645 |
| Unlisted preventive medicine service | 24 | $525 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 42 | $463 |
| Return visit (30+ min) | 47 | $453 |
| Short return visit | 15 | $67 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 16 Part D prescriptions in 2019. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$15 in 2021
A payment is not proof that care is biased.
| Cranial Technologies | Doc Band | $15 | 1 payment
|
See the published payment
| Cranial Technologies | Meals · 2021-01-22 | Doc Band | $15 |
Professional record
- NPI
- 1902900350
- Licence
- CA G605350
More record details
- Sole proprietor
- Yes
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 145 N California Avenue, Palo Alto, CA, 94301
- NPI first listed
- 2006-09-07
- NPI last updated
- 2011-02-27
This is when the NPI record was last certified, not a medical board exam.